STOUGHTON, Mass., Feb. 9 /PRNewswire/ -- STD Med, Inc., a manufacturer and innovator of medical devices located in Stoughton, Massachusetts is pleased to announce the acquisition of a new 32,000 sq. ft. facility in West Bridgewater, Massachusetts. This is in addition to the current footprint of 120,000 sq. ft. "We are excited to be growing and advancing the company during these difficult financial times," said Steven Tallarida, President STD Med, "we attribute this growth to the premise on which STD Med was founded 58 years ago by Primo Tallarida; hard work, the American Dream, and luck sure doesn't hurt."

This space will be used to expand the Company's cleanroom capacity to accommodate STD Med's growing base of business. STD Med anticipates an increase in its current workforce of close to 50 new jobs over the next 3 years. Additionally the facility will house several innovative STD Med incubated start-up companies including Spirus Medical, Inc. www.spirusmed.com , and Cardiosolutions, Inc., www.cardiosolutionsinc.com as well as a new venture capital firm, Makaira Venture Partners. Andrea Patisteas, Vice President Sales & Marketing said, "Our secret to success is new product innovation and continued customer service." The opening of this new facility is scheduled for summer 2010. For more on STD Med Inc. or its start-up companies, visit www.stdmed.com.